Objectives: To evaluate the usefulness of single-nucleotide polymorphism (SNP) array for prenatal genetic diagnosis of congenital heart defect (CHD), we used this approach to detect clinically significant copy number variants (CNVs) in fetuses with CHDs. Methods: A HumanCytoSNP-12 array was used to detect genomic samples obtained from 39 fetuses that exhibited cardiovascular abnormalities on ultrasound and had a normal karyotype. The relationship between CNVs and CHDs was identified by using genotype-phenotype comparisons and searching of chromosomal databases. All clinically significant CNVs were confirmed by real-time PCR. Results: CNVs were detected in 38/39 (97.4%) fetuses: variants of unknown significance were detected in 2/39 (5.1%), and clinically significant CNVs were identified in 7/39 (17.9%). In 3 of the 7 fetuses with clinically significant CNVs, 3 rare and previously undescribed CNVs were detected, and these CNVs encompassed the CHD candidate genes FLNA (Xq28 dup), BCOR (Xp11.4 dup), and RBL2 (16q12.2 del). Conclusion: Compared with conventional cytogenetic genomics, SNP array analysis provides significantly improved detection of submicroscopic genomic aberrations in pregnancies with CHDs. Based on these results, we propose that genomic SNP array is an effective method which could be used in the prenatal diagnostic test to assist genetic counseling for pregnancies with CHDs.

Keywords:
Congenital heart disease, Genetic counseling, Prenatal diagnosis
1.
Hoffman JI, Christianson R: Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 1978;42:641-647.
2.
Hoffman JI, Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-1900.
3.
China Ministry of Health: Birth defects prevention report (2012). Chin Mod Med 2012;19:1-2.
4.
Bentham J, Bhattacharya S: Genetic mechanisms controlling cardiovascular development. Ann NY Acad Sci 2008;1123:10-19.
5.
Lei YP, Zhang T, Li H, Wu BL, Jin L, Wang HY: VANGL2 mutations in human cranial neural-tube defects. N Engl J Med 2010;362:2232-2235.
6.
Andersen TA, Troelsen Kde L, Larsen LA: Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci 2014;71:1327-1352.
7.
Harris JA, Francannet C, Pradat P, Robert E: The epidemiology of cardiovascular defects. 2. A study based on data from three large registries of congenital malformations. Pediatr Cardiol 2003;24:222-235.
8.
Meberg A, Hals J, Thaulow E: Congenital heart defects - chromosomal anomalies, syndromes and extracardiac malformations. Acta Paediatr 2007;96:1142-1145.
9.
Schellberg R, Schwanitz G, Gravinghoff L, Kallenberg R, Trost D, Raff R, Wiebe W: New trends in chromosomal investigation in children with cardiovascular malformations. Cardiol Young 2004;14:622-629.
10.
Greenway SC, Pereira AC, Lin JC, et al: De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009;41:931-935.
11.
Thienpont B, Mertens L, de Ravel T, Eyskens B, Boshoff D, Maas N, Fryns JP, Gewillig M, Vermeesch JR, Devriendt K: Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007;28:2778-2784.
12.
Schaaf CP, Wiszniewska J, Beaudet AL: Copy number and SNP arrays in clinical diagnostics. Annu Rev Genom Hum Genet 2011;12:25-51.
13.
Kobrynski LJ, Sullivan KE: Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443-1452.
14.
Shprintzen RJ: Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008;14:3-10.
15.
Bittel DC, Yu S, Newkirk H, Kibiryeva N, Holt A 3rd, Butler MG, Cooley LD: Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by ACGH. Cytogenet Genome Res 2009;124:113-120.
16.
Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, Hummel M, Amato S, Tartaglia N, Berg J, Sutton VR, Lalani SR, Chinault AC, Cheung SW, Lupski JR, Patel A: 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 2008;82:214-221.
17.
Ng D, Thakker N, Corcoran CM, Donnai D, Perveen R, Schneider A, Hadley DW, Tifft C, Zhang L, Wilkie AO, van der Smagt JJ, Gorlin RJ, Burgess SM, Bardwell VJ, Black GC, Biesecker LG: Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 2004;36:411-416.
18.
Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gecz J, Moraine C, Marynen P, Fryns JP, Froyen G: Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005;77:442-453.
19.
Yan Y, Wu Q, Zhang L, Wang X, Dan S, Deng D, Sun L, Yao L, Ma Y, Wang L: Detection of submicroscopic chromosomal aberrations by array-based comparative genomic hybridization in fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2014;43:404-412.
20.
Xiang B, Zhu H, Shen Y, Miller DT, Lu K, Hu X, Andersson HC, Narumanchi TM, Wang Y, Martinez JE, Wu BL, Li P, Li MM, Chen TJ, Fan YS: Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases. J Mol Diagn 2010;12:204-212.
21.
Schmid M, Stary S, Blaicher W, Gollinger M, Husslein P, Streubel B: Prenatal genetic diagnosis using microarray analysis in fetuses with congenital heart defects. Prenat Diag 2012;32:376-382.
22.
Mademont-Soler I, Morales C, Soler A, Martinez-Crespo JM, Shen Y, Margarit E, Clusellas N, Obon M, Wu BL, Sanchez A: Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis. Ultrasound Obstet Gynecol 2013;41:375-382.
23.
Liao C, Li R, Fu F, Xie G, Zhang Y, Pan M, Li J, Li D: Prenatal diagnosis of congenital heart defect by genome-wide high-resolution SNP array. Prenat Diagn 2014;34:858-863.
24.
Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ: Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014;124:83-90.
25.
Allan LD: Cardiac anatomy screening: what is the best time for screening in pregnancy? Curr Opin Obstet Gynecol 2003;15:143-146.
26.
MacLellan WR, Garcia A, Oh H, Frenkel P, Jordan MC, Roos KP, Schneider MD: Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 2005;25:2486-2497.
27.
Sdek P, Zhao P, Wang Y, Huang CJ, Ko CY, Butler PC, Weiss JN, Maclellan WR: Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J Cell Biol 2011;194:407-423.
28.
Sirish P, Lopez JE, Li N, Wong A, Timofeyev V, Young JN, Majdi M, Li RA, Chen HS, Chiamvimonvat N: MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol 2012;52:264-272.
29.
Davoody A, Chen IP, Nanda R, Uribe F, Reichenberger EJ: Oculofaciocardiodental syndrome: a rare case and review of the literature. Cleft Palate Craniofac J 2012;49:e55-e60.
30.
Sujatha RS, Namita R: Oculofaciocardiodental syndrome: report of a rare case. Quintessence Int 2008;39:821-825.
31.
Horn D, Chyrek M, Kleier S, Luttgen S, Bolz H, Hinkel GK, Korenke GC, Riess A, Schell-Apacik C, Tinschert S, Wieczorek D, Gillessen-Kaesbach G, Kutsche K: Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome. Eur J Hum Genet 2005;13:563-569.
32.
Suzumori N, Kaname T, Muramatsu Y, Yanagi K, Kumagai K, Mizuno S, Naritomi K, Saitoh S, Sugiura-Ogasawara M: Prenatal diagnosis of X-linked recessive Lenz microphthalmia syndrome. J Obstet Gynaecol Res 2013;39:1545-1547.
33.
Duval D, Lardeux A, Le Tourneau T, Norris RA, Markwald RR, Sauzeau V, Probst V, Le Marec H, Levine R, Schott JJ, Merot J: Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation. Biochim Biophys Acta 2014;1843:234-244.
34.
Sheen VL, Dixon PH, Fox JW, et al: Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet 2001;10:1775-1783.
35.
Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F, Kwiatkowski DJ, Walsh CA: Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 2006;103:19836-19841.
36.
de Wit MC, de Coo IF, Lequin MH, Halley DJ, Roos-Hesselink JW, Mancini GM: Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol 2011;100:45-50.
37.
Neou P, Kyrkanides S, Gioureli E, Bartsocas CS: Melnick-Needles syndrome in a mother and her son. Genet Couns 1996;7:123-129.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.